Arab Finance: LVP PHARMA has purchased 166.965 million shares in Tenth of Ramadan Pharmaceutical Industries and Diagnostic Reagents Company (Rameda) at a value of EGP 846.513 million, or an average price of EGP 5.07 per share, according to a bourse filing.
Hence, the company increased its shareholding in Rameda to 31.498% from 23.15%.
Al Ahly Pharos Securities Brokerage handled the transaction, which was executed on June 8th.
In February, LVP PHARMA raised its stake in the EGX-listed company to 11.767% from 9.22%.